Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Conivaptan - Cumberland Pharmaceuticals

Drug Profile

Conivaptan - Cumberland Pharmaceuticals

Alternative Names: CI-1025; Vaprisol; YM-087

Latest Information Update: 09 Jul 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Astellas Pharma
  • Developer Alliance Healthcare; Cumberland Pharmaceuticals; DB Pharm Korea; Piramal Critical Care
  • Class Benzazepines; Small molecules
  • Mechanism of Action Vasopressin 1 receptor antagonists; Vasopressin V2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Hyponatraemia
  • Discontinued Heart failure

Most Recent Events

  • 09 Jul 2019 Discontinued - Phase-III for Hyponatraemia in South Africa (IV)
  • 31 Dec 2018 Cumberland Pharmaceuticals owns several US and international patents covering conivaptan
  • 24 Jun 2018 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top